Influence of the bifunctional chelate on the biological behavior of 99mtc-labeled chemotactic peptide conjugates

This publication has 18 references indexed in Scilit:

• Radio-LC-MS for the Characterization of ^99mTc-Labeled Bioconjugates
  Bioconjugate Chemistry, 1999
• Sources of radiochemical impurities in the 99mTc/S-unprotected MAG3 system
  Nuclear Medicine and Biology, 1995
• The contribution of nuclear medicine to the patient with infection
  European Journal of Nuclear Medicine and Molecular Imaging, 1995
• Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine
  Nuclear Medicine and Biology, 1995
• Effect of “co-ligand” on the biodistribution of 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides
  Nuclear Medicine and Biology, 1995
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis
  Gastroenterology, 1988
• Technique of leukocyte harvesting and labeling: Problems and perspectives
  Seminars in Nuclear Medicine, 1984
• Conformationally constrained chemotactic peptide analogs of high biological activity
  FEBS Letters, 1984
• Biodistribution and renal excretion of 99mTc-N,N'-bis-(mercaptoacetamido) ethylenediamine. Effect of renal tubular transport inhibitors
  International Journal of Nuclear Medicine and Biology, 1982